Life Science Company News

Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive Vice President and Head of Research and Development, and Strengthens Scientific Advisory Board with the Addition of Dr. Ad

Read more ››
By: GlobeNewswire - 23 Apr 2024

UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME

Read more ››
By: GlobeNewswire - 23 Apr 2024

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024

LifeMD to Participate in Upcoming Investor and Industry Conferences During May

Read more ››
By: GlobeNewswire - 23 Apr 2024

Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI

Read more ››
By: GlobeNewswire - 23 Apr 2024

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

Read more ››
By: GlobeNewswire - 23 Apr 2024

PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

Read more ››
By: GlobeNewswire - 23 Apr 2024

Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT

Read more ››
By: GlobeNewswire - 23 Apr 2024

OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors

Read more ››
By: GlobeNewswire - 23 Apr 2024

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Read more ››
By: GlobeNewswire - 23 Apr 2024

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Read more ››
By: GlobeNewswire - 23 Apr 2024

Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

USDA Grants Amfora Exemption for Its Patented, Gene-Edited, Ultra-High Protein Soy, Accelerating Path to Market

Read more ››
By: GlobeNewswire - 23 Apr 2024

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing

Read more ››
By: GlobeNewswire - 23 Apr 2024

Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach

Read more ››
By: GlobeNewswire - 23 Apr 2024

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101

Read more ››
By: GlobeNewswire - 23 Apr 2024
Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate